EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin-Reference-Cited by-同舟云学术

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

Published:2016-01 Issue:1 Volume:69 Page:60-69
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Cambier Samantha,Sylvester Richard J.,Collette Laurence,Gontero Paolo,Brausi Maurizio A.,van Andel George,Kirkels Wim J.,Silva Fernando Calais Da,Oosterlinck Willem,Prescott Stephen,Kirkali Ziya,Powell Philip H.,de Reijke Theo M.,Turkeri Levent,Collette Sandra,Oddens Jorg

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013

2. Babjuk M, Böhle A, Burger M, et al. Guidelines on non–muscle-invasive bladder cancer (Ta, T1 and CIS). European Association of Urology Web site. http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/.

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. The EORTC tables overestimate the risk of recurrence and progression in patients with non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables;Fernandez-Gomez;Eur Urol,2011

5. Prognostic factors in patients with non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials;Fernandez-Gomez;Eur Urol,2008

Cited by 483 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial for “Multiparametric MRI‐Based Deep Learning Radiomics Model for Assessing 5‐Year Recurrence Risk in Non‐Muscle Invasive Bladder Cancer”;Journal of Magnetic Resonance Imaging;2024-09-11

2. GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells;Cancer Cell International;2024-09-08

3. Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review;Urologic Oncology: Seminars and Original Investigations;2024-09

4. MicroRNA-146b-5p/FDFT1 Mediates Cisplatin Sensitivity in Bladder Cancer by Redirecting Cholesterol Biosynthesis to the Non-Sterol Branch;The International Journal of Biochemistry & Cell Biology;2024-09

5. Multiparametric MRI‐Based Deep Learning Radiomics Model for Assessing 5‐Year Recurrence Risk in Non‐Muscle Invasive Bladder Cancer;Journal of Magnetic Resonance Imaging;2024-08-21